ST
ARIA

Spot Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Spot Trading’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,000
Closed -$148K – 3833
2016
Q2 		$148K Buy
+20,000
New +$150K ﹤0.01% 2387
2016
Q1 		– Sell
-232,800
Closed -$1.46M – 4389
2015
Q4 		$1.46M Sell
232,800
-9,500
-4% -$62.3K 0.02% 1209
2015
Q3 		$1.42M Hold
242,300
– – 0.01% 1320
2015
Q2 		$2M Hold
242,300
– – 0.02% 1139
2015
Q1 		$2M Buy
242,300
+31,800
+15% +$235K 0.02% 1114
2014
Q4 		$1.45M Sell
210,500
-2,400
-1% -$15K 0.01% 1636
2014
Q3 		$1.15M Buy
212,900
+81,000
+61% +$473K 0.01% 2001
2014
Q2 		$840K Buy
131,900
+29,400
+29% +$202K ﹤0.01% 2273
2014
Q1 		$826K Buy
102,500
+17,900
+21% +$139K ﹤0.01% 2168
2013
Q4 		$577K Buy
84,600
+6,800
+9% +$36.7K ﹤0.01% 2370
2013
Q3 		$1.43M Buy
77,800
+76,000
+4,222% +$1.48M 0.01% 1642
2013
Q2 		$31K Buy
+1,800
New +$31.9K ﹤0.01% 3792

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Spot Trading's ARIA Position: Q3 2016 in Review

Spot Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 20,700 shares — an estimated $153K sold.

Spot Trading first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $723K in Q3 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Spot Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Spot Trading sold 20,700 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $153K.
  • Spot Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Spot Trading's Ariad Pharmaceuticals Inc position peaked at $723K in Q3 2014.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Spot Trading's 13F filing for Q3 2016, filed 31 Oct 2016.